Anika Therapeutics | 10-Q: Quarterly report
Anika Therapeutics | 8-K: Current report
Anika Therapeutics | 8-K: Anika Reports First Quarter 2024 Financial Results
Anika Therapeutics | 10-K/A: Annual report (Amendment)
Anika Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.7%)
Anika Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levitz Michael L
Anika Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Colleran David
Anika Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nunes Anne
Anika Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Blanchard Cheryl R
Anika Therapeutics | 10-K: Annual report
Anika Therapeutics | 8-K: Anika Reports Fourth Quarter and Year-End 2023 Financial Results
Anika Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Blanchard Cheryl R
Anika Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Colleran David
Anika Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nunes Anne
Anika Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levitz Michael L
Anika Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Caligan Partners LP(9.7%),David Johnson(9.7%), etc.
Anika Therapeutics | 8-K: Current report
Anika Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.22%)
Anika Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Trigran Investments, Inc.(Approximately 14.6%),Douglas Granat(Approximately 14.6%), etc.
Anika Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dimensional Fund Advisors LP(5.6%)
No Data